5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.07▼ | 10.07▼ | 10.07▼ | 10.09▲ | 10.08▲ |
MA10 | N/A | N/A | N/A | 10.08▲ | 10.08▲ |
MA20 | N/A | N/A | N/A | 10.07▲ | N/A |
MA50 | N/A | N/A | N/A | 10.08▲ | N/A |
MA100 | N/A | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.002▲ | N/A |
RSI | N/A | N/A | N/A | 58.954▲ | 66.828▲ |
STOCH | N/A | N/A | N/A | 2.353▼ | N/A |
WILL %R | N/A | N/A | N/A | -96.702▼ | -91.818▼ |
CCI | N/A | N/A | N/A | -12.204 | -13.081 |
CDL | $SOUL Doji Candlestick Pattern Detected | Set Alert |
Monday, September 29, 2025 09:36 AM
AstraZeneca laid out plans on Monday to switch to a direct listing of its shares in the United States, as the drugmaker seeks to maximise gains from a booming U.S. stock market, even as it said it was ...
|
Monday, September 15, 2025 11:20 AM
Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial ...
|
Tuesday, September 02, 2025 09:00 AM
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 10.091 | 10.091 | 10.091 | 10.091 | 0 |
29/09/25 | 10.0913 | 10.0913 | 10.0913 | 10.0913 | 102 |
26/09/25 | 10.08 | 10.085 | 10.08 | 10.085 | 7,800 |
25/09/25 | 10.08 | 10.08 | 10.08 | 10.08 | 120,600 |
24/09/25 | 10.08 | 10.08 | 10.08 | 10.08 | 1,000 |
23/09/25 | 10.08 | 10.081 | 10.08 | 10.081 | 71,900 |
22/09/25 | 11.00 | 11.00 | 10.07 | 10.08 | 1,700 |
19/09/25 | 10.08 | 10.08 | 10.08 | 10.08 | 2,800 |
18/09/25 | 10.07 | 10.07 | 10.07 | 10.07 | 24,600 |
17/09/25 | 10.07 | 10.07 | 10.066 | 10.07 | 5,600 |
|
|
||||
|
|
||||
|
|